Abstract
Leishmaniases are a group of diseases caused by protozoa of the genus Leishmania and endanger 350 million people worldwide. There are few available drugs for the treatment of this parasitic disease that present several drawbacks such as high toxicity and low efficacy, turning urgent the search for new drugs. The transmission occurs by the inoculation of metacyclic promastigotes into the h…